GO:0043403 skeletal muscle tissue regeneration: Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043403 (skeletal muscle tissue regeneration) is the biological process by which damaged skeletal muscle is repaired and restored after injury.
• The process is driven by coordinated activation, proliferation, and differentiation of muscle stem cells (satellite cells) and by a tightly regulated inflammatory and extracellular matrix response.
• Key regulatory genes include PAX7, MYOD1, MYF5, MYOG, MEF2C, and MET, which control satellite cell quiescence, activation, and myogenic differentiation.
• Defective skeletal muscle regeneration contributes to muscular dystrophies, age-related sarcopenia, and impaired recovery after volumetric muscle loss.
• Experimental models for studying GO:0043403 include cardiotoxin- or BaCl2-induced injury in mice, myotoxin-injected zebrafish, and in vitro myoblast differentiation assays.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in skeletal muscle regeneration.
Description
Skeletal muscle tissue regeneration (GO:0043403) is the biological process through which damaged skeletal muscle fibers are replaced or repaired to restore tissue architecture and contractile function. This process is essential for recovery from exercise-induced injury, trauma, ischemia, and myotoxic damage, and it depends on the coordinated action of resident muscle stem cells, immune cells, and the local extracellular environment. Understanding GO:0043403 is therefore central to muscle biology, regenerative medicine, and the development of therapies for muscle-wasting conditions. The process is not a single event but a temporally ordered program that includes degeneration and inflammation, satellite cell activation and proliferation, myoblast differentiation and fusion, and remodeling of the regenerated fiber and its niche. Each stage is controlled by defined transcription factors, signaling pathways, and cell-cell interactions that have been characterized in animal models and human tissue studies. Because regeneration capacity declines with age and in disease, researchers increasingly use genome-editing approaches to test which genes are causally required for efficient repair.
skeletal muscle tissue regeneration At A Glance
| GO ID | GO:0043403 |
|---|---|
| GO term | skeletal muscle tissue regeneration |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Restoration of skeletal muscle tissue after injury through satellite cell activation, myoblast differentiation, and fiber remodeling |
| Cellular drivers | Muscle satellite cells, myoblasts, macrophages, fibro-adipogenic progenitors, and endothelial cells |
| Key signaling | Notch, Wnt, myostatin, IGF-1, and inflammatory cytokine signaling |
| Experimental models | Cardiotoxin or BaCl2 injury in rodents, myotoxin injury in zebrafish, and in vitro myoblast differentiation |
| Disease relevance | Muscular dystrophies, sarcopenia, volumetric muscle loss, and impaired recovery after trauma |
What Is GO:0043403?
GO:0043403, skeletal muscle tissue regeneration, describes the biological process by which skeletal muscle tissue is regenerated after damage. It encompasses the cellular and molecular events that restore muscle fibers and their supporting structures, including activation of muscle stem cells, proliferation of myogenic precursors, differentiation and fusion into new fibers, and resolution of inflammation and fibrosis. The term is used in gene ontology annotation to capture the complete regenerative response rather than a single molecular step, and it is supported by experimental evidence from injury models and in vitro myogenesis systems.
Why Is skeletal muscle tissue regeneration Important in Cell Biology?
GO:0043403 is important because skeletal muscle has a limited but essential capacity for self-repair, and failure of this process underlies or exacerbates many human conditions, including muscular dystrophies, age-related muscle loss, and trauma-induced volumetric muscle loss. Mechanistic understanding of this process informs regenerative medicine strategies such as cell therapy, biomaterial scaffolds, and pharmacological modulation of myogenesis. In addition, genes annotated to this process are candidate targets for therapeutic genome editing, making GO:0043403 a central ontology term for translational muscle research.
• Provides the mechanistic basis for recovery from exercise-induced and traumatic muscle injury.
• Underlies satellite cell activation, proliferation, and differentiation into new muscle fibers.
• Is impaired in muscular dystrophies and contributes to progressive muscle weakness.
• Declines with aging, contributing to sarcopenia and reduced regenerative capacity.
• Is a target for tissue engineering and biomaterial-based regeneration strategies.
• Involves immune cell efferocytosis and inflammation resolution that can be therapeutically modulated.
• Requires extracellular matrix and connective tissue remodeling for functional recovery.
• Serves as a functional readout for CRISPR-based validation of muscle disease genes.
What Happens During skeletal muscle tissue regeneration?
Injury, degeneration, and inflammatory response
In simple terms: First, the damaged muscle is cleared and an inflammatory signal calls repair cells to the site.
After injury, disrupted myofibers undergo necrosis and release damage-associated signals that recruit immune cells, particularly macrophages, to the injured area. This inflammatory phase is required for subsequent repair, but its duration and intensity must be tightly controlled because unresolved inflammation impairs regeneration. Macrophages shift from a pro-inflammatory to a pro-regenerative phenotype and participate in efferocytosis, the clearance of apoptotic cells, which promotes the resolution of inflammation and supports myogenic progression. Connective tissue remodeling also begins during this phase and influences the mechanical and biochemical environment for regenerating fibers.
Satellite cell activation and proliferation
In simple terms: Muscle stem cells wake up, divide, and make more copies of themselves to supply new muscle.
Muscle satellite cells, marked by PAX7, are normally quiescent and reside between the myofiber sarcolemma and the basal lamina. Injury triggers their activation, re-entry into the cell cycle, and proliferation, a step controlled by myogenic regulatory factors including MYOD1 and MYF5. A subset of activated satellite cells self-renews to maintain the stem cell pool, while others commit to differentiation. This proliferative expansion is a rate-limiting step for successful regeneration and is influenced by Notch, Wnt, and growth factor signaling.
Myoblast differentiation and fusion
In simple terms: The new muscle cells stop dividing, specialize, and fuse together to form replacement muscle fibers.
Proliferating myoblasts exit the cell cycle and differentiate under the control of MYOG and MEF2 family transcription factors. Differentiating myoblasts align and fuse to form multinucleated myotubes, which mature into regenerated myofibers. This step requires coordinated membrane remodeling, cytoskeletal reorganization, and expression of muscle-specific structural proteins. In vitro myoblast differentiation assays are widely used to study this stage and to test gene function.
Fiber maturation, reinnervation, and niche restoration
In simple terms: The new fibers grow, reconnect to nerves, and rebuild their surrounding support tissue.
Newly formed myofibers undergo growth and maturation, including re-establishment of the neuromuscular junction and restoration of contractile function. The extracellular matrix and connective tissue are remodeled to restore tissue architecture, a process that involves coordinated synthesis and degradation of matrix components. Satellite cells return to quiescence and repopulate their niche, which is essential for future regenerative capacity. Failure at this stage can result in fibrosis, fatty infiltration, and persistent weakness.
Resolution of inflammation and efferocytosis
In simple terms: The cleanup phase ends inflammation so that repair can finish properly.
Efferocytosis, the phagocytic clearance of apoptotic cells by macrophages, is a key driver of inflammation resolution during skeletal muscle regeneration. This process promotes a shift toward pro-regenerative macrophage phenotypes and supports myoblast differentiation. Defects in efferocytosis are associated with impaired regeneration and persistent inflammation. Therefore, GO:0043403 includes not only myogenic events but also the immune resolution programs that enable them.
Key Genes Involved in GO:0043403 skeletal muscle tissue regeneration
The following genes and proteins are experimentally implicated in skeletal muscle tissue regeneration (GO:0043403) and are commonly studied in injury and myogenesis models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAX7 | Satellite cell specification and maintenance | Marker of muscle stem cells; required for regeneration |
| MYOD1 | Myogenic determination and satellite cell activation | Central regulator of myoblast commitment |
| MYF5 | Early myogenic specification | Co-regulates satellite cell activation |
| MYOG | Myoblast differentiation and fusion | Terminal differentiation marker |
| MEF2C | Myogenic transcription and fiber maturation | Cooperates with MYOG in differentiation |
| MET | Satellite cell activation | Receptor tyrosine kinase linked to injury response |
| NOTCH1 | Satellite cell quiescence and self-renewal | Controls stem cell pool maintenance |
| WNT7A | Satellite cell proliferation and myogenesis | Wnt pathway regulator of regeneration |
| MSTN | Negative regulation of muscle growth | Myostatin signaling limits regeneration |
| IGF1 | Promotes myoblast proliferation and differentiation | Anabolic regulator of muscle repair |
| MURF1 | Protein degradation and muscle atrophy | Atrophy-related gene affecting recovery |
| FOXO3 | Atrophy and proteolysis regulation | Links stress signaling to muscle mass |
| CD68 | Macrophage marker in injured muscle | Immune cell contribution to regeneration |
| MRC1 | Pro-regenerative macrophage phenotype | Efferocytosis and inflammation resolution |
| COL1A1 | Extracellular matrix remodeling | Connective tissue repair after injury |
| MMP2 | Matrix degradation and remodeling | Facilitates cell migration and repair |
| VEGFA | Angiogenesis in regenerating muscle | Supports nutrient and oxygen delivery |
How Is skeletal muscle tissue regeneration Regulated?
Skeletal muscle tissue regeneration is regulated at multiple levels. Satellite cell quiescence and activation are controlled by Notch and Wnt signaling, while myogenic differentiation is driven by MYOD1, MYOG, and MEF2 transcription factors. Inflammatory signaling and macrophage polarization regulate the transition from degeneration to repair, and efferocytosis is required for timely resolution of inflammation. Growth factor signaling, including IGF-1 and myostatin, modulates myoblast proliferation and differentiation. Extracellular matrix remodeling by matrix metalloproteinases and collagen deposition also regulates the regenerative environment. Together, these pathways ensure that regeneration proceeds in a temporally ordered manner, and their dysregulation contributes to fibrosis or failed repair.
skeletal muscle tissue regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAX7 | Satellite cell dysfunction in muscular dystrophy | Pax7 knockout or knock-in reporter mice |
| MYOD1 | Impaired myogenic differentiation | Myod1 knockout myoblasts and injury models |
| MYOG | Defective myoblast fusion | Myog knockout mice and in vitro fusion assays |
| MSTN | Muscle hypertrophy and regeneration imbalance | Mstn knockout mice |
| COL1A1 | Fibrosis after muscle injury | Col1a1 conditional knockout mice |
Muscular dystrophies
In Duchenne muscular dystrophy and related disorders, repeated cycles of muscle degeneration and regeneration eventually exhaust satellite cell function, leading to progressive weakness and fibrosis. Genes controlling regeneration, such as PAX7 and MYOD1, are therefore studied as modifiers of dystrophic pathology. Experimental models include mdx mice and patient-derived myoblasts.
Sarcopenia and age-related muscle loss
Aging is associated with reduced satellite cell function and impaired regeneration, contributing to sarcopenia and loss of muscle mass and strength. Understanding GO:0043403 in aged muscle may identify targets to restore regenerative capacity. Models include aged rodent injury models and human muscle biopsies.
Volumetric muscle loss and trauma
Severe trauma or surgical resection can cause volumetric muscle loss that exceeds the intrinsic regenerative capacity of skeletal muscle. Tissue engineering and biomaterial strategies aim to augment GO:0043403 in these settings. Experimental models include surgical muscle defect models in rodents.
Fibrosis and impaired regeneration
Dysregulated extracellular matrix remodeling during regeneration can lead to fibrosis and fatty infiltration, which impair muscle function. Connective tissue regeneration after eccentric contraction injury is a well-studied model of this balance. Targeting matrix remodeling genes is a potential therapeutic strategy.
From skeletal muscle tissue regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for satellite cell activation? | CRISPR knockout in primary myoblasts or mouse injury model |
| Does a disease-associated variant alter myoblast differentiation? | CRISPR point mutation knock-in in myoblast cell line |
| Where is a protein expressed during regeneration? | Knock-in of fluorescent or epitope tag |
| Does overexpression of a growth factor enhance repair? | CRISPR overexpression or lentiviral overexpression in injured muscle |
| Which genes regulate inflammation resolution? | Knockout of macrophage genes in injury models |
| Does matrix remodeling gene loss cause fibrosis? | Conditional knockout in fibro-adipogenic progenitors |
How to Study the skeletal muscle tissue regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cardiotoxin injury histology | Fiber regeneration and central nuclei | In vivo regeneration staging |
| Single-cell RNA-seq | Cell state transitions and gene programs | Discovery of regulators |
| In vitro myoblast differentiation | Fusion index and myotube formation | Functional gene testing |
| Immunofluorescence | Protein localization and marker expression | Satellite cell and myoblast tracking |
| Force measurement | Contractile recovery | Functional regeneration assessment |
| Macrophage efferocytosis assay | Clearance of apoptotic cells | Inflammation resolution studies |
| Matrix remodeling assays | Collagen deposition and MMP activity | Fibrosis and connective tissue repair |
| CRISPR screening | Gene requirement in regeneration | Pooled knockout or activation screens |
Injury models and histology
Cardiotoxin or barium chloride injection into rodent skeletal muscle is a standard method to induce synchronized regeneration, followed by histological assessment of fiber size, central nuclei, and fibrosis. These models allow temporal analysis of GO:0043403 stages. Zebrafish myotoxin injury models provide complementary genetic tractability.
Transcriptomics and single-cell RNA sequencing
RNA sequencing and single-cell RNA sequencing of injured muscle can identify gene expression programs associated with satellite cell activation, differentiation, and immune cell states. These approaches are useful for discovering novel regulators of GO:0043403. Spatial transcriptomics can further resolve niche interactions.
In vitro myogenesis assays
Primary myoblasts or C2C12 cells can be induced to differentiate in vitro, and fusion index, myotube diameter, and myogenic gene expression are measured. These assays enable rapid functional testing of candidate genes. CRISPR editing can be combined with these assays for causal studies.
Imaging and functional assessment
Immunofluorescence for PAX7, MYOD1, and MYOG allows spatial and temporal mapping of regeneration stages. In vivo functional recovery can be assessed by grip strength or force measurements after injury. Advanced imaging such as intravital microscopy can track satellite cell behavior.
How CRISPR Can Be Used to Study GO:0043403 skeletal muscle tissue regeneration
Knockout
CRISPR knockout of candidate genes in myoblasts or mouse models can test whether a gene is required for satellite cell activation, differentiation, or inflammation resolution during GO:0043403. Knockout models are particularly useful for genes such as PAX7, MYOD1, and MYOG. Pooled knockout screens can identify novel regulators in an unbiased manner.
Point Mutation
CRISPR point mutation knock-in can model disease-associated variants in genes involved in muscle regeneration and test their effects on myoblast function. This approach is valuable when complete knockout is lethal or when a specific amino acid change is suspected to alter protein function. Point mutation models can be combined with in vitro differentiation assays.
Knock-in
Knock-in of fluorescent reporters or epitope tags at endogenous loci enables tracking of satellite cells and myoblasts during regeneration. Tagged knock-in models can also be used to study protein interactions and localization in regenerating muscle. These models are compatible with live imaging and flow cytometry.
Overexpression
CRISPR activation or transgenic overexpression can test whether increased expression of a growth factor or transcription factor enhances skeletal muscle regeneration. Overexpression models are useful for gain-of-function studies of genes such as IGF1 or WNT7A. These models can be applied in injury settings to assess therapeutic potential.
How EDITGENE Supports skeletal muscle tissue regeneration Research
Researchers studying skeletal muscle tissue regeneration-related genes often need to determine whether a candidate gene is causally involved in satellite cell activation, myoblast differentiation, or inflammation resolution. EDITGENE provides CRISPR-based cell and animal model services that enable functional validation of genes annotated to GO:0043403.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle tissue regeneration research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DAG1 Knockout HeLa Cell Line | EDJ-KQ29 | Human | 1605 | Details Get a Quote |
| CFLAR Knockout HEK293 Cell Line | EDJ-KQ555 | Human | 8837 | Details Get a Quote |
| PPP3CA Knockout HEK293 Cell Line | EDJ-KQ733 | Human | 5530 | Details Get a Quote |
| MYOD1 Knockout HEK293 Cell Line | EDJ-KQ1334 | Human | 4654 | Details Get a Quote |
| MSTN Knockout HEK293 Cell Line | EDJ-KQ2039 | Human | 2660 | Details Get a Quote |
| DMD Knockout HEK293 Cell Line | EDJ-KQ3154 | Human | 1756 | Details Get a Quote |
| COX8A Knockout HEK293 Cell Line | EDJ-KQ3609 | Human | 1351 | Details Get a Quote |
| MYF6 Knockout HEK293 Cell Line | EDJ-KQ3614 | Human | 4618 | Details Get a Quote |
| DAG1 Knockout HEK293 Cell Line | EDJ-KQ3800 | Human | 1605 | Details Get a Quote |
| LARGE1 Knockout HEK293 Cell Line | EDJ-KQ6508 | Human | 9215 | Details Get a Quote |
| HDGFL2 Knockout HEK293 Cell Line | EDJ-KQ10178 | Human | 84717 | Details Get a Quote |
| EYS Knockout HEK293 Cell Line | EDJ-KQ13346 | Human | 346007 | Details Get a Quote |
| MCUB Knockout HEK293 Cell Line | EDJ-KQ14223 | Human | 55013 | Details Get a Quote |
| MYMX Knockout HEK293 Cell Line | EDJ-KQ14343 | Human | 101929726 | Details Get a Quote |
| CFLAR Knockout HeLa Cell Line | EDJ-KQ18133 | Human | 8837 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About skeletal muscle tissue regeneration
What is GO:0043403?
GO:0043403 is the Gene Ontology term for skeletal muscle tissue regeneration, the biological process by which damaged skeletal muscle is repaired and restored after injury.
What happens during skeletal muscle tissue regeneration?
The process includes injury and inflammation, satellite cell activation and proliferation, myoblast differentiation and fusion, and fiber maturation with niche restoration.
What genes are involved in skeletal muscle tissue regeneration?
Key genes include PAX7, MYOD1, MYF5, MYOG, MEF2C, MET, NOTCH1, WNT7A, MSTN, and IGF1, among others.
Which cells drive skeletal muscle regeneration?
Muscle satellite cells are the primary stem cells, supported by macrophages, fibro-adipogenic progenitors, and endothelial cells.
How is skeletal muscle regeneration studied experimentally?
Common models include cardiotoxin or BaCl2 injury in rodents, myotoxin injury in zebrafish, and in vitro myoblast differentiation assays.
Why does skeletal muscle regeneration fail in disease?
In muscular dystrophies and aging, repeated injury and satellite cell exhaustion lead to fibrosis and impaired repair.
What is the role of macrophages in muscle regeneration?
Macrophages clear debris, promote inflammation resolution through efferocytosis, and support myogenic progression.
Can CRISPR be used to study skeletal muscle regeneration?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in regeneration.
What is the role of the extracellular matrix in muscle regeneration?
Matrix remodeling is required for fiber growth and niche restoration, and dysregulation can cause fibrosis.
How does aging affect skeletal muscle regeneration?
Aging reduces satellite cell function and regenerative capacity, contributing to sarcopenia and muscle weakness.
Conclusion
GO:0043403, skeletal muscle tissue regeneration, is a multi-stage biological process that restores muscle after injury through coordinated satellite cell activation, myoblast differentiation, immune resolution, and matrix remodeling. Its dysregulation contributes to muscular dystrophies, sarcopenia, and impaired recovery after trauma, making it a key target for regenerative medicine. CRISPR-based functional genomics provides a powerful approach to identify and validate the genes that control this process. EDITGENE supports this research with tailored knockout, point mutation, knock-in, overexpression, and screening services.
References
- 1. Chargé SB et al.. 2004. Cellular and molecular regulation of muscle regeneration.. Physiol Rev 84(1):209-38 PMID: 14715915
- 2. Tidball JG. 2011. Mechanisms of muscle injury, repair, and regeneration.. Compr Physiol 1(4):2029-62 PMID: 23733696
- 3. Alarcin E et al.. 2021. Current Strategies for the Regeneration of Skeletal Muscle Tissue.. Int J Mol Sci 22(11) PMID: 34072959
- 4. Lu HH et al.. 2024. Ionic medicine: Exploiting metallic ions to stimulate skeletal muscle tissue regeneration.. Acta Biomater 190:1-23 PMID: 39454933
- 5. Liu J et al.. 2018. Current Methods for Skeletal Muscle Tissue Repair and Regeneration.. Biomed Res Int 2018:1984879 PMID: 29850487
- 7. Mackey AL et al.. 2017. Connective tissue regeneration in skeletal muscle after eccentric contraction-induced injury.. J Appl Physiol (1985) 122(3):533-540 PMID: 27562842
- 8. Juban G et al.. 2021. Efferocytosis during Skeletal Muscle Regeneration.. Cells 10(12) PMID: 34943775
